Published in Biochem Biophys Res Commun on May 27, 1999
Androgen receptor serine 81 phosphorylation mediates chromatin binding and transcriptional activation. J Biol Chem (2012) 1.13
Loss of androgen receptor in aging and oxidative stress through Myb protooncoprotein-regulated reciprocal chromatin dynamics of p53 and poly(ADP-ribose) polymerase PARP-1. J Biol Chem (2008) 0.98
SOD mimetics: a novel class of androgen receptor inhibitors that suppresses castration-resistant growth of prostate cancer. Mol Cancer Ther (2011) 0.92
Phosphorylation of bone morphogenetic protein-15 and growth and differentiation factor-9 plays a critical role in determining agonistic or antagonistic functions. Endocrinology (2007) 0.89
Differential regulation of the transcriptional activity of the glucocorticoid receptor through site-specific phosphorylation. Biologics (2008) 0.87
Distinctly different dynamics and kinetics of two steroid receptors at the same response elements in living cells. PLoS One (2014) 0.82
Proline-Directed Androgen Receptor Phosphorylation. J Mol Genet Med (2013) 0.76
Androgen receptor-dependent and -independent mechanisms driving prostate cancer progression: Opportunities for therapeutic targeting from multiple angles. Oncotarget (2016) 0.75
Corepressive function of nuclear receptor coactivator 2 in androgen receptor of prostate cancer cells treated with antiandrogen. BMC Cancer (2016) 0.75
Increased risk of lymphoma in sicca syndrome. Ann Intern Med (1978) 4.63
c-erbB-2 expression and response to adjuvant therapy in women with node-positive early breast cancer. N Engl J Med (1994) 3.89
erbB-2, p53, and efficacy of adjuvant therapy in lymph node-positive breast cancer. J Natl Cancer Inst (1998) 3.56
Dose and dose intensity of adjuvant chemotherapy for stage II, node-positive breast carcinoma. N Engl J Med (1994) 3.54
Thymidine and thymine incorporation into deoxyribonucleic acid: inhibition and repression by uridine of thymidine phosphorylase of Escherichia coli. J Bacteriol (1967) 2.41
Production of autoantibodies by CD5-expressing B lymphocytes from patients with chronic lymphocytic leukemia. J Exp Med (1989) 2.16
Increased spontaneous activity of antibody-forming cells in the peripheral blood of patients with active SLE. Arthritis Rheum (1977) 2.03
Requirement of Bmp8b for the generation of primordial germ cells in the mouse. Mol Endocrinol (2000) 1.98
The effect of antimicrotubule agents on signal transduction pathways of apoptosis: a review. Cancer Chemother Pharmacol (1999) 1.87
Short communication: rapid detection of milk fat adulteration with vegetable oil by fluorescence spectroscopy. J Dairy Sci (2013) 1.75
Hematologic aspects of systemic lupus erythematosus. Current concepts. Ann Intern Med (1977) 1.68
Mutational status of codons 12 and 13 of the N- and K-ras genes in tissue and cell lines derived from primary and metastatic prostate carcinomas. Cancer Invest (1993) 1.50
Isolation and purification of L-methionine-alpha-deamino-gamma-mercaptomethane-lyase (L-methioninase) from Clostridium sporogenes. Cancer Res (1973) 1.50
Relationship between toxicity and obesity in women receiving adjuvant chemotherapy for breast cancer: results from cancer and leukemia group B study 8541. J Clin Oncol (1996) 1.49
Synergism of cytotoxic effects of vinorelbine and paclitaxel in vitro. Cancer Invest (2000) 1.49
Survival of patients who had salvage castration after failure on bicalutamide monotherapy for stage (D2) prostate cancer. Cancer Invest (2000) 1.37
The extent of genetic variation in the CCR5 gene. Nat Genet (1997) 1.24
De-repression of the p21 promoter in prostate cancer cells by an isothiocyanate via inhibition of HDACs and c-Myc. Int J Oncol (2008) 1.19
HER-2/neu and p53 expression versus tamoxifen resistance in estrogen receptor-positive, node-positive breast cancer. J Clin Oncol (2000) 1.17
Study of lymphocyte subpopulations in normal humans and patients with systemic lupus erythematosus by fractionation of peripheral blood lymphocytes on a discontinuous Ficoll gradient. Clin Exp Immunol (1976) 1.17
Fourier transform infrared spectroscopy and site-directed isotope labeling as a probe of local secondary structure in the transmembrane domain of phospholamban. Biophys J (1996) 1.16
Ribavirin: efficacy in the treatment of murine autoimmune disease. Science (1977) 1.15
The heat shock protein 90 chaperone complex: an evolving therapeutic target. Curr Cancer Drug Targets (2008) 1.13
Methionine requirement and replacement by homocysteine in tissue cultures of selected rodent and human malignant and normal cells. Cancer Res (1978) 1.10
Hypertension and renal disease in systemic lupus erythematosus. Arch Intern Med (1976) 1.10
Repression of androgen receptor in prostate cancer cells by phenethyl isothiocyanate. Carcinogenesis (2006) 1.10
Dual action on promoter demethylation and chromatin by an isothiocyanate restored GSTP1 silenced in prostate cancer. Mol Carcinog (2007) 1.09
Simultaneous picosecond and femtosecond solitons delivered from a nanotube-mode-locked all-fiber laser. Opt Lett (2014) 1.01
Deoxycytidine and deoxythymidine kinase activities in plasma of mice and patients with neoplastic disease. Cancer Res (1982) 1.01
Biological effects of enzymatic deprivation of L-methionine in cell culture and an experimental tumor. Cancer Res (1973) 1.00
Phase I trial of granulocyte-macrophage colony-stimulating factor plus high-dose cyclophosphamide given every 2 weeks: a Cancer and Leukemia Group B study. J Natl Cancer Inst (1993) 1.00
Influence of consumption of probiotics on the plasma lipid profile: a meta-analysis of randomised controlled trials. Nutr Metab Cardiovasc Dis (2011) 0.98
Immunofluorescence studies of anti-T cell antibodies and T cells in systemic lupus erythematosus. Selective loss of brightly staining T cells in active disease. Arthritis Rheum (1979) 0.97
The current causes of death in patients with malignant melanoma. Eur J Cancer (1978) 0.96
Phase I trial of the combination of daily estramustine phosphate and intermittent docetaxel in patients with metastatic hormone refractory prostate carcinoma. Ann Oncol (1999) 0.96
Tissue culture-induced locus-specific alteration in DNA methylation and its correlation with genetic variation in Codonopsis lanceolata Benth. et Hook. f. Plant Cell Rep (2007) 0.96
Mycobacterium tuberculosis infection in solid organ transplant recipients: experience from a single center in China. Transplant Proc (2008) 0.93
Giant retroperitoneal pleomorphic lipoma. Am J Surg Pathol (1987) 0.93
Distribution pattern and enzymic hypermethylation of inverted repetitive DNA sequences in P815 mastocytoma cells. Biochim Biophys Acta (1979) 0.93
Mutation in Bmp7 exacerbates the phenotype of Bmp8a mutants in spermatogenesis and epididymis. Dev Biol (2001) 0.93
A phase II study of docetaxel (Taxotere), estramustine, and low-dose hydrocortisone in men with hormone-refractory prostate cancer: preliminary results of cancer and leukemia group B Trial 9780. Semin Oncol (1999) 0.92
Global variation and uniformity of eggshell thickness for chicken eggs. Poult Sci (2012) 0.92
Phase I and pharmacokinetic study of LY309887: a specific inhibitor of purine biosynthesis. Cancer Chemother Pharmacol (2001) 0.92
Possible association of the MAG locus with schizophrenia in a Chinese Han cohort of family trios. Schizophr Res (2005) 0.91
Effect of nutritional and enzymatic methionine deprivation upon human normal and malignant cells in tissue culture. Cancer Res (1980) 0.91
Tetrahydrouridine: Physiologic disposition and effect upon deamination of cytosine arabinoside in man. Cancer Treat Rep (1977) 0.90
Tumor therapy by deprivation of L-methionine: rationale and results. Cancer Treat Rep (1979) 0.90
Purification of deoxycytidine kinases from two P815 murine neoplasms and their separation from deoxyguanosine kinase. Arch Biochem Biophys (1976) 0.89
alpha-Adducin gene and essential hypertension in China. Clin Exp Hypertens (2001) 0.89
Pharmacokinetics of ara-C and ara-U in plasma and CSF after high-dose administration of cytosine arabinoside. Cancer Chemother Pharmacol (1992) 0.89
Quantitation of mixed-base populations of HIV-1 variants by automated DNA sequencing with BODIPY dye-labeled primers. Biotechniques (1998) 0.88
Effect of tetrahydrouridine on the clinical pharmacology of 1-beta-D-arabinofuranosylcytosine when both drugs are coinfused over three hours. Cancer Res (1988) 0.88
Therapy of refractory/relapsed acute myeloid leukemia and blast crisis of chronic myeloid leukemia with the combination of cytosine arabinoside, tetrahydrouridine, and carboplatin. Cancer Chemother Pharmacol (1993) 0.88
In vitro metabolism of 1-beta-D-arabinofuranosylcytosine and 1-beta-2'-fluoroarabino-5-iodocytosine in normal and herpes simplex type 1 virus-infected cells. Biochem Pharmacol (1982) 0.87
Unique synergism or antagonism of combinations of chemotherapeutic and hormonal agents in human prostate cancer cell lines. Br J Urol (1997) 0.87
Tyrosine structural changes detected during the photoactivation of rhodopsin. J Biol Chem (1998) 0.86
Cardiac glycosides in partly submerged shoots of Digitalis lanata. Planta Med (1993) 0.86
Adhesive growth of pancreatic islet cells on a polyglycolic acid fibrous scaffold. Transplant Proc (2008) 0.86
Implications of applied research for prognosis and therapy of breast cancer. Crit Rev Oncol Hematol (2008) 0.85
Phase II trial of mitomycin, vinblastine, and cisplatin (MVP) in non-small cell bronchogenic carcinoma. Cancer Treat Rep (1983) 0.85
Changes of thyroid hormone levels in epileptic patients. J Tongji Med Univ (1994) 0.85
Extraction and analytic procedures for cytosine arabinoside and 1-beta-D-arabinofuranosyluracil and their 5'-mono-, di-, and tri-phosphates. Cancer Treat Rep (1977) 0.85
Intensive postremission therapy in adults with acute nonlymphocytic leukemia using various dose schedules of ara-C: a progress report from the CALGB. Cancer and Leukemia Group B. Semin Oncol (1987) 0.85
Therapy of refractory/relapsed acute leukemia with cytosine arabinoside plus tetrahydrouridine (an inhibitor of cytidine deaminase)--a pilot study. Leukemia (1991) 0.85
Morphological, ultrastructural, and genetic characterization of an unusual T-cell lymphoma in a patient with sinus histiocytosis with massive lymphadenopathy. Am J Hematol (1995) 0.85
Colitis and docetaxel-based chemotherapy. Lancet (2000) 0.84
DNA content in Barrett's esophagus and esophageal malignancy. Am J Gastroenterol (1987) 0.84
Differential binding of nuclear c-ets-1 protein to an intron I fragment of the c-myb gene in growth versus differentiation. Cell Growth Differ (1994) 0.84
Fine needle aspiration biopsy resulting in a local anaphylactic reaction. Acta Cytol (1987) 0.84
Hepatic and renal artery rupture due to Aspergillus and Mucor mixed infection after combined liver and kidney transplantation: a case report. Transplant Proc (2008) 0.84
A reexamination of PSC 833 (Valspodar) as a cytotoxic agent and in combination with anticancer agents. Cancer Chemother Pharmacol (2001) 0.83
Activation of casein kinase II in ML-1 human myeloblastic leukemia cells requires IGF-1 and transferrin. J Leukoc Biol (1995) 0.83
Unique induction of p21(WAF1/CIP1)expression by vinorelbine in androgen-independent prostate cancer cells. Br J Cancer (2003) 0.83
Preoperative plasma D-dimer levels predict survival in patients with operable non-small cell lung cancer independently of venous thromboembolism. Eur J Surg Oncol (2013) 0.83
Acquired factor VIII inhibitors--successful treatment with an oral outpatient regimen. Am J Hematol (1999) 0.83
Phase I trial of vinzolidine. Cancer Treat Rep (1984) 0.82
Isolation of a rice endophytic bacterium, Pantoea sp. Sd-1, with ligninolytic activity and characterization of its rice straw degradation ability. Lett Appl Microbiol (2013) 0.82
A loading dose/continuous infusion schedule of fludarabine phosphate in chronic lymphocytic leukemia. J Clin Oncol (1991) 0.82
High grade dysplasia in Crohn's colitis characterized by flow cytometry. J Clin Gastroenterol (1987) 0.82
Enzymatic degradation of cichoric acid in Echinacea purpurea preparations. J Nat Prod (2000) 0.82
Studies on drug resistance. I. Distribution of l-beta-D-arabinofuranosylcytosine, cytidine and deoxycytidine in mice bearing ara-C-sensitive and-resistant P815 neoplasms. Biochem Pharmacol (1969) 0.82
Successful production of offspring after superovulation and in vitro culture of embryos from domestic ferrets (Mustela putorius furos). Reproduction (2001) 0.82
Polymorphisms of the TIM-1 gene are associated with rheumatoid arthritis in the Chinese Hui minority ethnic population. Genet Mol Res (2012) 0.82
A novel strategy with standardized reference extract qualification and single compound quantitative evaluation for quality control of Panax notoginseng used as a functional food. J Chromatogr A (2013) 0.82
Zoladex: a sustained-release, monthly luteinizing hormone-releasing hormone analogue for the treatment of advanced prostate cancer. J Clin Oncol (1987) 0.81
In vitro effects of dexrazoxane (Zinecard) and classical acute leukemia therapy: time to consider expanded clinical trials? Leukemia (2001) 0.81
Moyamoya disease caused by leptospiral cerebral arteritis. Chin Med J (Engl) (1980) 0.81
Differential effect of vinorelbine versus paclitaxel on ERK2 kinase activity during apoptosis in MCF-7 cells. Br J Cancer (2001) 0.81
The teratogenic effect of 1-beta-D-arabinofuranosylcytosine in the rat. Protection by deoxycytidine. Biochem Pharmacol (1968) 0.81
Comparative cost analysis of home and hospital treatment. Prog Clin Biol Res (1986) 0.81
Adrenal steroid levels in castrated men with prostatic carcinoma treated with aminoglutethimide plus hydrocortisone. Cancer Res (1987) 0.81